The Centers for Medicare & Medicaid Services Friday finalized changes to the Medicare Advantage and prescription drug programs for contract year 2020. Specifically, the final rule implements Bipartisan Budget Act of 2018 provisions that expanded MA coverage of telehealth services, and policies to better integrate coverage for Medicare and Medicaid dual-eligible beneficiaries. The rule also includes updates to the MA and Part D Quality Rating System and to certain program integrity provisions. CMS estimates the final rule will result in $4.5 billion in savings over 10 years, largely due to recovery of overpayments to MA plans. CMS did not finalize its proposed MA risk adjustment data validation provisions, which it intends to address in a future final rule.

Related News Articles

Headline
The AHA today responded to a Centers for Medicare & Medicaid Services request for information by offering solutions for improving maternal and child health…
Headline
The Centers for Medicare & Medicaid Services yesterday released a fact sheet for state and local governments seeking Medicare, Medicaid or Children’s…
Headline
Over 1,750 Medicare Part D prescription drug plans and Medicare Advantage plans with prescription drug coverage have applied to offer lower insulin costs…
Headline
The Government Accountability Office today named three new members to the Medicare Payment Advisory Commission through April 2023. They are: Wayne…
Headline
AHA yesterday urged the Federal Communications Commission to grant expedited approval to its request that the agency extend the COVID-19 Telehealth Program to…
Headline
Health experts agree that telemedicine’s ability to bring virtual expertise to bedsides everywhere is a vital tool for fighting COVID-19. On this AHA podcast,…